J2650 HCPCS code: Injection, prednisolone acetate, up to 1 ml
J2650 is the HCPCS Level II code for injection, prednisolone acetate, up to 1 ml. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1982-01-01 |
| Last action effective | 1997-01-01 |
What changed for J2650
- 1982-01-01: J2650 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2650?
J2650 is the HCPCS Level II code for injection, prednisolone acetate, up to 1 ml. Short descriptor: "Prednisolone acetate inj".
Does Medicare cover J2650?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
Related J26 codes
- J2601 — Injection, vasopressin (baxter), 1 unit
- J2670 — Injection, tolazoline hcl, up to 25 mg
- J2675 — Injection, progesterone, per 50 mg
- J2679 — Injection, fluphenazine hcl, 1.25 mg
- J2680 — Injection, fluphenazine decanoate, up to 25 mg
- J2690 — Injection, procainamide hcl, up to 1 gm
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2650
- Watch J2650 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2650
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.